{"product_id":"ucla-16th-annual-ucla-liver-diseases-symposium-2023","title":"UCLA 16th Annual UCLA Liver Diseases Symposium 2023","description":"\u003ch1 class=\"product_title entry-title\"\u003eUCLA 16th Annual UCLA Liver Diseases Symposium 2023\u003c\/h1\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eInclude: 9 videos + 9 pdfs, size: 3.1 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: hepatologists, radiologists and surgeons\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cp class=\"desc_normal\"\u003eThe 16th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTARGET AUDIENCE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHepatologists, Radiologists, Surgeons, Nurses, Allied Healthcare Professionals, Fellows, and Residents.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eLEARNING OBJECTIVES\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt the conclusion of this program, participants will be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDiagnose and develop a treatment strategy for acute kidney injury in patients with cirrhosis.\u003c\/li\u003e\n\u003cli\u003eIdentify indications and evaluation for liver transplantation, as well as the role of MELD in organ allocation.\u003c\/li\u003e\n\u003cli\u003eReview the pros and cons of Transjugular Intrahepatic Portosystemic Shunts (TIPS) in patients with cirrhosis and portal hypertension, including expanding indications.\u003c\/li\u003e\n\u003cli\u003eImplement new and novel strategies for the treatment of hepatocellular carcinoma (HCC).\u003c\/li\u003e\n\u003cli\u003eDiscuss specific liver disorders and injuries in women, as well as pregnancy hepatic complications.\u003c\/li\u003e\n\u003cli\u003eTreat non-alcoholic fatty liver disease and be able to employ noninvasive tests for diagnosis and risk stratification.\u003c\/li\u003e\n\u003cli\u003eReview the treatment of alcohol hepatitis, including long-term follow up, and understand controversies associated with early liver transplantation.\u003c\/li\u003e\n\u003cli\u003eDiscuss updates in the management of patients with viral hepatitis B, including those immunotolerant, and considerations for stopping antiviral therapy.\u003c\/li\u003e\n\u003cli\u003eDiagnose acute liver failure, and risk stratify patients according to available laboratory results and clinical parameters.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBronchure.pdf\u003c\/li\u003e\n\u003cli\u003eCurrent Evaluation and Treatment of NASH.mp4\u003c\/li\u003e\n\u003cli\u003eCurrent Evaluation and Treatment of NASH.pdf\u003c\/li\u003e\n\u003cli\u003eDebate Treating Patients in the Hepatitis B Gray Zone and Stopping Hepatitis B Therapy.mp4\u003c\/li\u003e\n\u003cli\u003eDebate Treating Patients in the Hepatitis B Gray Zone and Stopping Hepatitis B Therapy.pdf\u003c\/li\u003e\n\u003cli\u003eEvaluation, Listing and Allocation in Liver Transplantation.mp4\u003c\/li\u003e\n\u003cli\u003eIncreasing Role of TIPS in the Management of Patients with Cirrhosis.mp4\u003c\/li\u003e\n\u003cli\u003eIncreasing Role of TIPS in the Management of Patients with Cirrhosis.pdf\u003c\/li\u003e\n\u003cli\u003eLiver Diseases in Women, Including those who are Pregnant.mp4\u003c\/li\u003e\n\u003cli\u003eLiver Diseases in Women, Including those who are Pregnant.pdf\u003c\/li\u003e\n\u003cli\u003eLong Term Care of Patients with Alcohol Liver Disease including those with Alcohol Hepatitis.mp4\u003c\/li\u003e\n\u003cli\u003eLong Term Care of Patients with Alcohol Liver Disease including those with Alcohol Hepatitis.pdf\u003c\/li\u003e\n\u003cli\u003ePanel Case Discussion Acute Liver Failure.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Case Discussion Acute Liver Failure.pdf\u003c\/li\u003e\n\u003cli\u003ePanel Case Discussion Multi-disciplinary Approach to Liver Cancer.mp4\u003c\/li\u003e\n\u003cli\u003ePanel Case Discussion Multi-disciplinary Approach to Liver Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eUpdate on Treatment of Acute Kidney Injury in Patients with Cirrhosis.mp4\u003c\/li\u003e\n\u003cli\u003eUpdate on Treatment of Acute Kidney Injury in Patients with Cirrhosis.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954627874914,"sku":"MED-AMB07099","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/UCLA-16th-Annual-UCLA-Liver-Diseases-Symposium-2023.jpg?v=1779381133","url":"https:\/\/meducourse.com\/products\/ucla-16th-annual-ucla-liver-diseases-symposium-2023","provider":"Meducourse","version":"1.0","type":"link"}